IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$366M
AUM Growth
+$96.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
132
New
Increased
Reduced
Closed

Top Buys

1
+$32.6M
2
+$16.3M
3
+$13.4M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$12.7M
5
ALPN
Alpine Immune Sciences Inc
ALPN
+$6.77M

Top Sells

1
+$10.1M
2
+$9.16M
3
+$7.92M
4
PCVX icon
Vaxcyte
PCVX
+$7.26M
5
GPCR icon
Structure Therapeutics
GPCR
+$7.07M

Sector Composition

1 Healthcare 92.55%
2 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$26.5M 7.26%
+70,000
2
$24.2M 6.62%
680,370
-112,550
3
$23.8M 6.5%
590,243
+53,523
4
$19.1M 5.23%
+200,000
5
$19.1M 5.22%
473,126
6
$19M 5.2%
258,142
-19,892
7
$14.9M 4.06%
1,991,005
-927,421
8
$12.9M 3.53%
+877,500
9
$12.8M 3.5%
+132,640
10
$12M 3.29%
+2,650,000
11
$11.3M 3.08%
194,982
+52,216
12
$10.5M 2.87%
518,519
13
$9.83M 2.69%
233,394
-64,400
14
$9.29M 2.54%
+487,248
15
$8.51M 2.33%
+368,130
16
$8.5M 2.33%
505,862
17
$8.11M 2.22%
746,069
18
$7.31M 2%
+319,000
19
$7.18M 1.97%
239,726
-415,000
20
$6.93M 1.9%
+440,000
21
$6.57M 1.8%
25,088
22
$5.91M 1.62%
979,462
+465,361
23
$4.92M 1.35%
+216,620
24
$4.81M 1.31%
+500,000
25
$4.46M 1.22%
200,000
+50,000
1
2 3 4 5